文献速递免疫规划传染病防控与疫情报告

展示多杀性巴氏杆菌PlpE蛋白的大肠杆菌外膜囊泡的免疫保护效力

Immunoprotective efficacy of Escherichia coli-derived outer membrane vesicles displaying PlpE protein of Pasteurella multocida.
PubMed 文献 · Vaccine · 2024-11-26

本研究将多杀性巴氏杆菌PMWSG-4株PlpE脂蛋白基因克隆入pBAD-ClyA载体,由大肠杆菌表达融合PlpE抗原的重组外膜囊泡(OMV-PlpE)。免疫鸭的抗原特异性抗体显著增加(P<0.001),免疫后28天脾组织IL-2、IL-4、IL-10和IFN-γ基因表达显著上调(P<0.001),血清对PMWSG-4株有显著杀菌作用(P<0.001)。以20 LD50剂量多杀性巴氏杆菌腿部肌肉攻毒,重组OMV-PlpE提供100%保护,并显著减轻组织损伤和细菌定植(P<0.001)。

要点

  • 大肠杆菌表达的多杀性巴氏杆菌PlpE融合外膜囊泡可显著提高鸭抗原特异性抗体水平(P<0.001)。
  • 免疫鸭脾组织IL-2、IL-4、IL-10和IFN-γ基因表达较未免疫对照组显著上调(P<0.001)。
  • 20 LD50多杀性巴氏杆菌攻毒后重组OMV-PlpE提供100%保护,并显著减轻组织损伤和细菌定植(P<0.001)。

核心结论

  • 重组OMV-PlpE可诱导鸭抗原特异性抗体产生、上调脾组织免疫相关基因表达、增强血清杀菌作用,并在20 LD50攻毒下提供100%保护,为多杀性巴氏杆菌疫苗研发提供参考。

研究设计与样本

  • 将多杀性巴氏杆菌PMWSG-4株PlpE脂蛋白编码基因克隆入pBAD-ClyA载体,由大肠杆菌表达融合PlpE抗原的重组外膜囊泡(OMV-PlpE),并在鸭中评价其免疫保护效力。

主要发现

  • 免疫鸭的抗原特异性抗体产生显著增加(P<0.001)。
  • 免疫后28天,免疫鸭脾组织IL-2、IL-4、IL-10和IFN-γ基因表达较未免疫对照组显著上调(P<0.001)。
  • 免疫鸭活性血清对PMWSG-4株具有显著杀菌作用(P<0.001)。
  • 以20 LD50剂量多杀性巴氏杆菌腿部肌肉攻毒,重组OMV-PlpE提供100%保护。
  • 组织病理学检查和组织细菌载量检测显示,OMV-PlpE显著减轻组织损伤和细菌定植(P<0.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Pasteurella multocida (P. multocida), a pathogenic bacterium known to induce duck cholera, stands as a significant contributor to bacterial diseases afflicting the duck industry, causing substantial annual economic losses on a global scale. In this study, the genes encoding the lipoproteins PlpE of P. multocida strain PMWSG-4 was cloned, inserted into the pBAD-ClyA vector, and the recombinant outer membrane vesicles (OMVs) fused with PlpE antigen of P. multocida was expressed by Escherichia coli (E. coli). Ducks immunized with OMV-PlpE had significantly (P < 0.001) increased production of antigen-specific antibodies. Moreover, at 28 days post-immunization, the expression of genes associated with immune response, including interleukin (IL)-2, IL-4, IL-10, and interferon (IFN)-γ in the spleen tissue of immunized ducks were significantly (P < 0.001) up-regulated compared to unimmunized ducks in the control group. And the active serum had significant bactericidal effects against the PMWSG-4 strain (P < 0.001). The protective efficacy of the vaccines was evaluated by leg muscle challenge with 20 LD50 doses of P. multocida, with the recombinant OMV-PlpE conferring 100 % protection. Histopathological examination and tissue bacterial load detection revealed that OMV-PlpE mitigated tissue damage and bacterial colonization to a statistically significant extent (P < 0.001). These findings serve as a valuable reference for the development of vaccines against P. multocida.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Li Y, Chen L, Xiao J, et al. Immunoprotective efficacy of Escherichia coli-derived outer membrane vesicles displaying PlpE protein of Pasteurella multocida. Vaccine. 2024. PMID: 39603075. doi:10.1016/j.vaccine.2024.126532

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。